Literature DB >> 24793962

Comparing cardiopulmonary exercise testing in severe COPD patients with and without pulmonary hypertension.

Wilawan Thirapatarapong1, Hilary F Armstrong2, Matthew N Bartels3.   

Abstract

PURPOSE: To determine; (i) the effect of PH on exercise capacity, gas exchange and oxygen pulse; (ii) the variables that correlate with mean pulmonary artery pressure (mPAP) in severe COPD patients.
METHODS: We reviewed 98 severe COPD patients who had pulmonary function, right heart catheterisation, and cardiopulmonary exercise testing (CPET) performed within six months of each other. PH was defined by a resting mPAP > 25 mmHg. COPD patients with and without PH were compared using the independent samples t-test and Mann-Whitney U test. Pearson correlation coefficients were used to assess the relationship between continuous variables.
RESULTS: PH was present in 32% of patients and the majority of PH was mild (mPAP, 25-35 mmHg). Peak workload, oxygen uptake and oxygen pulse on CPET were significantly lower in the PH group. Mean PAP was found to inversely correlate with peak oxygen uptake, with a tendency towards lower six-minute walk distance. No difference between two groups was seen in any of the gas exchange variables.
CONCLUSION: In severe COPD, there is a relatively high percentage of PH which causes a decrease in exercise capacity and oxygen pulse without significantly altered ventilation as measured by CPET. Lower than expected exercise performance without a change in pulmonary function may indicate a need for evaluation for possible PH.
Copyright © 2014 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  COPD; Cardiopulmonary exercise testing; Exercise capacity; Gas exchange; Pulmonary hypertension

Mesh:

Substances:

Year:  2014        PMID: 24793962     DOI: 10.1016/j.hlc.2013.12.015

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  9 in total

1.  Impact Of Peak Oxygen Pulse On Patients With Chronic Obstructive Pulmonary Disease.

Authors:  Chih-Wei Wu; Po-Chun Hsieh; Mei-Chen Yang; I-Shiang Tzeng; Yao-Kuang Wu; Chou-Chin Lan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-11-20

2.  Effect of pulmonary hypertension on exercise capacity and gas exchange in patients with chronic obstructive pulmonary disease living at high altitude.

Authors:  Mauricio Gonzalez-Garcia; Carlos Eduardo Aguirre-Franco; Leslie Vargas-Ramirez; Margarita Barrero; Carlos A Torres-Duque
Journal:  Chron Respir Dis       Date:  2022 Jan-Dec       Impact factor: 3.115

3.  Comparison of Functional Capacity and Symptoms of COPD Patients with and without Pulmonary Hypertension.

Authors:  Fikriye Kalkan; Elif Yilmazel Ucar; Kamuran Kalkan; Omer Araz
Journal:  Eurasian J Med       Date:  2020-06-02

4.  Exercise capacity in COPD patients with exercise-induced pulmonary hypertension.

Authors:  Ingunn Skjørten; Janne Mykland Hilde; Morten Nissen Melsom; Jonny Hisdal; Viggo Hansteen; Kjetil Steine; Sjur Humerfelt
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-31

5.  Ventilatory power, a cardiopulmonary exercise testing parameter for the prediction of pulmonary hypertension at right heart catheterization.

Authors:  Michele Correale; Ilenia Monaco; Armando Ferraretti; Lucia Tricarico; Monica Sicuranza; Anna Maria Gallotta; Ennio Sascia Formica; Gianfranco Acanfora; Matteo Di Biase; Natale Daniele Brunetti
Journal:  Int J Cardiol Heart Vasc       Date:  2020-04-21

6.  The value of cardiopulmonary exercise testing in the diagnosis of pulmonary hypertension.

Authors:  Qin Luo; Xue Yu; Zhihui Zhao; Qing Zhao; Xiuping Ma; Qi Jin; Lu Yan; Yi Zhang; Zhihong Liu
Journal:  J Thorac Dis       Date:  2021-01       Impact factor: 2.895

Review 7.  Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide.

Authors:  Agustín Roberto García; Lucilla Piccari
Journal:  Curr Opin Pulm Med       Date:  2022-07-16       Impact factor: 2.868

8.  Cardiopulmonary exercise test and PaO2 in evaluation of pulmonary hypertension in COPD.

Authors:  Ingunn Skjørten; Janne Mykland Hilde; Morten Nissen Melsom; Jonny Hisdal; Viggo Hansteen; Kjetil Steine; Sjur Humerfelt
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-12-22

9.  Value of Cardiopulmonary Exercise Testing in Prognostic Assessment of Patients with Interstitial Lung Diseases.

Authors:  Beate Stubbe; Till Ittermann; Anita Grieger; Charlotte Walther; Sven Gläser; Ralf Ewert
Journal:  J Clin Med       Date:  2022-03-14       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.